Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.JU.0000554775.94661.aa | DOI Listing |
Publication Analysis
Top Keywords
editorial comment
4
editorial
1
Similar Publications
Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients.
Breast Cancer
January 2025
Tepe Prime, MKA Breast Cancer Clinic, 06800, Ankara, Turkey.
Isatuximab-Based Therapy for Multiple Myeloma. Reply.
N Engl J Med
January 2025
Centre Hospitalier Universitaire de Lille, Lille, France
Isatuximab-Based Therapy for Multiple Myeloma.
N Engl J Med
January 2025
Tan Tock Seng Hospital, Singapore, Singapore
Invasive Strategy for Older Patients with MI. Reply.
N Engl J Med
January 2025
Newcastle University, Newcastle upon Tyne, United Kingdom
Invasive Strategy for Older Patients with MI.
N Engl J Med
January 2025
Medical University of Innsbruck, Innsbruck, Austria
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!